|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Prometheus Biosciences (NASDAQ: RXDX) through any online brokerage.
There are no as such competitors for Prometheus Biosciences.
The latest price target for Prometheus Biosciences (NASDAQ: RXDX) was reported by Guggenheim on 2021-04-06. The analyst firm set a price target for 40.00 expecting RXDX to rise to within 12 months (a possible 112.77% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Prometheus Biosciences (NASDAQ: RXDX) is $18.8 last updated Mon Apr 12 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Prometheus Biosciences.
There is no upcoming split for Prometheus Biosciences.